SCYX SCYNEXIS INC

SCYX financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1178253 Exchange: Nasdaq SIC: 2834 (Pharmaceutical Preparations)
Showing 3 of 13 annual and 0 of 52 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Non-accelerated filer<br>Smaller reporting company
Entity Type
Operating
Public Float
$25.65M (Jun 2025)
Industry (SIC)
2834 Pharmaceutical Preparations
Fiscal Year End
December (1231)
Phone
201-884-5485
EIN
562181648
Headquarters
JERSEY CITY, NJ, 07302-6548
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$19.22M
Net Income
$-10.24M
Total Assets
$74.97M
Total Equity
$66.93M
Total Debt
-
Free Cash Flow
-
Ratios
Operating Margin
-117.7%
Net Margin
-53.3%
Return on Equity
-15.3%
Return on Assets
-13.7%
Current Ratio
9.65x

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

SCYNEXIS INC generated $20.60M of revenue in fiscal 2025, with net loss of $8.61M and an operating cash outflow of $5.28M. At $20.60M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $3.75M in fiscal 2024, revenue recorded a 449.9% year-over-year increase. Diluted earnings per share were -$0.17, translating the period’s attributable earnings into the amount reported for each diluted share. Diluted shares averaged 49.93M; this is the reported share base over which the company’s diluted per-share earnings were spread. Compared with 48.51M diluted shares in fiscal 2024, the current 49.93M base was 2.9% higher. At period end, total assets were $59.03M, framing the scale of the company’s operating and financing commitments. Revenue equaled 0.35x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

The reported operating result was an operating loss of $16.07M, reflecting costs that exceeded gross profit. An operating margin of -78.0% reflected costs exceeding revenue-level gross profit by 78.0% of sales. After all below-operating-line items, the company recorded a net loss of $8.61M for the fiscal year. The net loss equaled 41.8% of revenue, showing the bottom-line deficit relative to the company’s sales base. The company reported a pretax loss of $8.61M, before the effect of income taxes. Measured against revenue, the pretax deficit represented 41.8%. Income tax expense totaled $0.00, providing the reported tax component that separates pretax and after-tax earnings. Relative to period-end equity, the net loss represented 17.4%. The loss-to-assets relationship was 14.6%, placing the bottom-line deficit against the company’s resource base. Compared with a $21.29M net loss in fiscal 2024, the current loss improved to $8.61M.

Liquidity and Capital Structure

At period end, the $59.03M asset base was financed through $9.65M of liabilities and $49.38M of equity. Current assets were $40.37M against $5.73M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. The current ratio was 7.04x, with current assets exceeding current liabilities and providing a short-term liquidity cushion. Cash and equivalents totaled $21.26M, identifying the most liquid reported component available within the broader current-asset balance. The cash balance equaled 370.8% of current liabilities, showing how much near-term coverage came from cash alone. Equity equaled 83.6% of assets, showing the shareholder-capital layer within the company’s balance sheet. Liabilities represented 16.4% of total assets, quantifying the liability-funded share of the company’s resource base. The cash-to-assets relationship was 36.0%, comparing reported cash and equivalents with the full positive asset balance. Compared with $90.64M in fiscal 2024, the current asset base moved 34.9% and finished lower. Book equity was 10.4% lower than fiscal 2024 equity of $55.08M, showing how shareholder capital changed year over year. Compared with $16.05M in fiscal 2024, the current cash balance moved 32.4% and finished higher.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $5.28M, rather than cash generation from operations. The operating cash outflow narrowed to $5.28M from $24.01M in fiscal 2024.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for SCYNEXIS INC
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $20.60M $3.75M $140.14M
OPERATING EXPENSES
R&D Expense $22.28M $26.41M $30.93M
SG&A Expense $14.40M $14.46M $20.92M
Operating Income $-16.07M $-37.12M $72.67M
NON-OPERATING INCOME / EXPENSE
Interest Expense - - $3.13M
Interest Income $2.18M $4.29M $3.95M
Other Income/Expense $7.47M $15.98M $-5.49M
Pretax Income $-8.61M $-21.14M $67.18M
Income Tax $0 $151.00K $138.00K
Net Income $-8.61M $-21.29M $67.04M
PER SHARE & SUPPLEMENTAL
Diluted EPS $-0.17 $-0.44 $1.39
Diluted Shares 49.93M 48.51M 48.39M
EBITDA - $-37.12M $73.25M
Depreciation & Amortization - $0 $580.00K
Balance Sheet
ASSETS
Cash & Equivalents $21.26M $16.05M $34.05M
Short-term Investments $18.77M $43.25M $40.31M
Accounts Receivable - - $0
Inventory - - $0
Other Current Assets $17.00K $1.23M $4.91M
Current Assets $40.37M $72.18M $102.12M
Intangible Assets - - $0
Other Noncurrent Assets - - $0
Noncurrent Assets $18.65M $18.46M $26.30M
Total Assets $59.03M $90.64M $128.41M
LIABILITIES
Accounts Payable $2.23M $4.57M $7.15M
Other Current Liabilities $478.00K $788.00K $0
Current Liabilities $5.73M $24.10M $16.30M
Noncurrent Liabilities $3.92M $11.47M $39.15M
Total Liabilities $9.65M $35.57M $55.45M
EQUITY
Common Stock $46.00K $41.00K $40.00K
Additional Paid-in Capital $434.47M $431.57M $428.17M
Retained Earnings $-385.14M $-376.54M $-355.25M
Total Equity $49.38M $55.08M $72.96M
Total Liabilities & Equity $59.03M $90.64M $128.41M
SUPPLEMENTAL
Shares Outstanding 43.54M 37.97M 37.21M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $-5.28M $-24.01M $60.16M
Capital Expenditures - - -
Cash from Investing $24.31M $6.15M $-34.88M
Cash from Financing $-14.17M $-139.00K $-36.72M
Free Cash Flow - - -
Beginning Cash (CFS) $16.60M $34.59M -
Net Change in Cash $4.85M $-18.00M -
Effect of FX on Cash - - -
Calculated Ending Cash $21.45M $16.60M -
Cash per BS $21.26M $16.05M $34.05M
Cash scope difference (CFS − BS) $189.00K $544.00K $543.00K
Cash per CFS $21.45M $16.60M $34.59M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is SCYNEXIS INC's annual revenue?

SCYNEXIS INC reported $19.22M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is SCYNEXIS INC profitable?

No. SCYNEXIS INC reported $-10.24M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.